Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
$4.39 million NIH grant awarded to study the link between atrial myopathy and dementia

$4.39 million NIH grant awarded to study the link between atrial myopathy and dementia

Cardiac rehabilitation after TAVR underutilized by majority of patients

Cardiac rehabilitation after TAVR underutilized by majority of patients

Health experts redefine cardiovascular disease risk, prevention and management

Health experts redefine cardiovascular disease risk, prevention and management

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

Self‐administration of investigational intranasal spray may be a new option to treat rapid heartbeat

Could metformin be a game changer for heart health in non-diabetics?

Could metformin be a game changer for heart health in non-diabetics?

The importance of using the American Heart Association-recommended technique for blood pressure measurement

The importance of using the American Heart Association-recommended technique for blood pressure measurement

International experts discuss recent advances in the diagnosis and treatment of atrial fibrillation

International experts discuss recent advances in the diagnosis and treatment of atrial fibrillation

DOAC use associated with reduction in dementia risk compared to traditional blood thinners

DOAC use associated with reduction in dementia risk compared to traditional blood thinners

Ohio State University launches first-in-world clinical trial of heart failure device

Ohio State University launches first-in-world clinical trial of heart failure device

Study finds semaglutide provides benefits for patients with obesity phenotype of heart failure and HFpEF

Study finds semaglutide provides benefits for patients with obesity phenotype of heart failure and HFpEF

Sex-based disparities in cardiovascular care may be linked to higher stroke risk among females

Sex-based disparities in cardiovascular care may be linked to higher stroke risk among females

Stressful life events and insomnia may increase risk of atrial fibrillation in postmenopausal women

Stressful life events and insomnia may increase risk of atrial fibrillation in postmenopausal women

Easy-to-implement strategy more than doubles new diagnoses of cardiovascular disease

Easy-to-implement strategy more than doubles new diagnoses of cardiovascular disease

Modern blood thinners linked to reduced risk of bleeding

Modern blood thinners linked to reduced risk of bleeding

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

Trial finds no benefit of minimizing atrial pacing in patients with sinus node dysfunction

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Pulsed field ablation safe, effective for the treatment of paroxysmal atrial fibrillation

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Ablation more effective than medical therapy in patients with end-stage heart failure, study shows

Ablation more effective than medical therapy in patients with end-stage heart failure, study shows

MRI-guided ablation improves outcomes for younger AFib patients, study shows

MRI-guided ablation improves outcomes for younger AFib patients, study shows

NOAH-AFNET 6 trial: Oral anticoagulation not recommended for patients with atrial high rate episodes

NOAH-AFNET 6 trial: Oral anticoagulation not recommended for patients with atrial high rate episodes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.